These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 19460075)

  • 21. Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs (INTRINSIC RV): design and clinical protocol.
    Olshansky B; Day J; McGuire M; Pratt T
    Pacing Clin Electrophysiol; 2005 Jan; 28(1):62-6. PubMed ID: 15660805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jumping in before the water is hot: the need to support randomized controlled clinical trials.
    Epstein AE
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):867-9. PubMed ID: 15333076
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac-resynchronization therapy.
    Carrigan TP; Sipahi I
    N Engl J Med; 2010 Jan; 362(2):177; author reply 179. PubMed ID: 20077590
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cardiac resynchronization therapy].
    Karczmarewicz S
    Kardiol Pol; 2003 Jul; 59(7):83-5. PubMed ID: 14560359
    [No Abstract]   [Full Text] [Related]  

  • 26. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed defibrillation testing after CRT-D implant-weighing competing risks.
    Saxon L
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1284-5. PubMed ID: 16403057
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac devices in emergency department heart failure patients.
    Neuenschwander JF
    Heart Fail Clin; 2009 Jan; 5(1):63-73, vi-vii. PubMed ID: 19026387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early mortality in implantable cardioverter defibrillator patients: from randomized controlled trials to real life.
    Köbe J; Eckardt L
    Europace; 2009 Jun; 11(6):694-6. PubMed ID: 19470594
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads.
    Cano Ó; Andrés A; Alonso P; Osca J; Sancho-Tello MJ; Olagüe J; Martínez-Dolz L
    Europace; 2017 Jan; 19(1):96-102. PubMed ID: 26847075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac-resynchronization therapy.
    Wilson JR
    N Engl J Med; 2010 Jan; 362(2):178; author reply 179. PubMed ID: 20077591
    [No Abstract]   [Full Text] [Related]  

  • 32. The dilemma of transvenous cardiac rhythm devices in hemodialysis patients: time to consider the epicardial approach?
    Asif A; Salman LH; Lopera GG; Carrillo RG
    Kidney Int; 2011 Jun; 79(12):1267-9. PubMed ID: 21625255
    [No Abstract]   [Full Text] [Related]  

  • 33. Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities.
    Whellan DJ; Adams S; Bowerman L
    Prog Cardiovasc Dis; 2011; 54(2):107-14. PubMed ID: 21875510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization therapy: which device to implant?
    Leclercq C; Mabo C; Daubert JC
    Arch Cardiovasc Dis; 2008 Jan; 101(1):55-60. PubMed ID: 18391874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective.
    Sauer WH; Bristow MR
    J Interv Card Electrophysiol; 2008 Jan; 21(1):3-11. PubMed ID: 18044015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions.
    Rauwolf T; Guenther M; Hass N; Schnabel A; Bock M; Braun MU; Strasser RH
    Europace; 2007 Nov; 9(11):1041-7. PubMed ID: 17897927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart failure in search of a cure.
    Torre-Amione G
    Methodist Debakey Cardiovasc J; 2009; 5(3):1. PubMed ID: 20308956
    [No Abstract]   [Full Text] [Related]  

  • 38. Ventricular perforation by a cardioverter lead in a small child.
    Schreiber C; Hausleiter J; Lange R
    Cardiol Young; 2004 Apr; 14(2):197. PubMed ID: 15691410
    [No Abstract]   [Full Text] [Related]  

  • 39. MY APPROACH to cybersecurity for cardiac implantable electronic devices.
    Baranchuk A; Alexander B; Haseeb S
    Trends Cardiovasc Med; 2019 Feb; 29(2):129-130. PubMed ID: 30396783
    [No Abstract]   [Full Text] [Related]  

  • 40. Conservative treatment of pacemaker pocket infection: is it a viable option?
    Glikson M
    Europace; 2013 Apr; 15(4):474-5. PubMed ID: 23180645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.